Discussion of: "The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review"
Am J Surg
.
2017 Dec;214(6):1102-1103.
doi: 10.1016/j.amjsurg.2017.09.024.
Epub 2017 Sep 30.
Authors
James M Chang
1
,
Heidi E Kosiorek
2
,
Nabil Wasif
1
,
Richard J Gray
1
,
Chee-Chee H Stucky
1
,
Donald W Northfelt
3
,
Karen S Anderson
3
,
Ann E McCullough
4
,
Idris Tolgay Ocal
4
,
Barbara A Pockaj
5
Affiliations
1
Section of Surgical Oncology, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
2
Department of Biostatistics, Mayo Clinic Arizona, Phoenix, AZ, USA.
3
Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
4
Department of Pathology, Mayo Clinic, Phoenix, AZ, USA.
5
Section of Surgical Oncology, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA. Electronic address:
[email protected]
.
PMID:
29037421
DOI:
10.1016/j.amjsurg.2017.09.024
No abstract available
Publication types
Comment
MeSH terms
Axilla
Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Lobular
Humans
Lymph Node Excision
Lymph Nodes
Neoadjuvant Therapy*
Neoplasm Staging
Sentinel Lymph Node Biopsy*